Honored to be recognized as a finalist in the HCP Education category for our work with the Novo Nordisk Xultophy team: “Leveraging the Power of NPP to Meet Customer Needs.”
Our own David Laros explores how pharma marketers are using AI today to enhance their engagement strategies in the latest issue of Pharmaceutical Market Europe
Interesting article in Pharmaceutical Market Europe magazine explores the many ways Artificial Intelligence offers potential for pharma – including the type of personalized communications we’re doing for our clients.
Our VP of Global HCP Analytics, David Laros, shares his perspective on how to determine, measure, and optimize the right multichannel mix.
Nice coverage of our data-driven approach to designing, measuring, and optimizing in-app mobile campaigns, with commentary from Patrick Aysseh of our Tomorrow Networks division.
Aptus Health is leveraging artificial intelligence to provide its clients with a deeper understanding of how HCPs consume data to better equip them to reach, engage with and influence this critical cohort.
Developments in data-collection and artificial-intelligence tools will impact how pharma marketers promote products said experts—including Tom Wassel, Director of Analytics at Aptus Health—at the ePharma Impact conference in New York on Wednesday.
To help our client re-educate physicians on a new indication for a therapy, we developed a data-driven digital campaign driven by our proprietary Aptus Propensity Index™ that funnels individual HCPs into different engagement journeys based on historical and predictive behaviors.
To capitalize on its brands’ favorable formulary positioning, we helped our client develop a Market Access Pull-Through Program (MAPP) powered by Aptus Health’s Tomorrow Networks division.
We’re honored to have been named a finalist in the 2018 MM&M Awards in the “Best use of Data/Analytics” category for our entry, “Boehringer Ingelheim and Aptus Health for Spiriva Respimat: Synchronized HCP and Consumer Campaign at the Point of Care and Beyond.”
Our own David Laros, VP of analytics and commercial effectiveness, is quoted alongside other industry experts in this recent article that appears in PharmaVOICE magazine, underscoring the power of predictive data and the value of analyzing disparate data sets across multiple healthcare…
Our VP of analytics and commercial effectiveness sits down for a brief interview with an editor from MM&M magazine to discuss how pharma can use data insights to foster engagement with HCPs.